The Conversation (0)
NeuroMetrix Reports Q4 and Full Year 2017 Financial Results
Jan. 25, 2018 08:47AM PST
Medical Device Investing
NeuroMetrix (Nasdaq:NURO) reported financial and business highlights for the quarter ended December 31, 2017. As quoted in the update: Q4 2017 revenue of $4.9 million grew 33% from $3.7 million in Q4 2016. Quell contributed $3.7 million and DPNCheck added $0.8 million revenue. Full year 2017 revenue of $17.1 million grew 42% from $12.0 million …
NeuroMetrix (Nasdaq:NURO) reported financial and business highlights for the quarter ended December 31, 2017.
As quoted in the update:
- Q4 2017 revenue of $4.9 million grew 33% from $3.7 million in Q4 2016. Quell contributed $3.7 million and DPNCheck added $0.8 million revenue.
- Full year 2017 revenue of $17.1 million grew 42% from $12.0 million in 2016. Quell contributed $12.4 million and DPNCheck contributed $3.1 million revenue.
- Fourth quarter Quell shipments totaled 26,496 devices and 36,556 electrode reorder packages. This compared with 14,301 devices and 19,993 electrode reorder packages in Q4 2016.
